Inhibitors | Comment | Organism | Structure |
---|---|---|---|
2-(3,4-diethoxyphenyl)-N-(4-phenyl-1,3-thiazol-2-yl)acetamide | - |
Escherichia coli | |
2-(3-bromophenyl)-N-(4-phenyl-1,3-thiazol-2-yl)acetamide | - |
Escherichia coli | |
2-(3-bromophenyl)-N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]acetamide | - |
Escherichia coli | |
2-(3-chlorophenyl)-N-(4-phenyl-1,3-thiazol-2-yl)acetamide | - |
Escherichia coli | |
2-(3-methoxyphenyl)-N-(4-phenyl-1,3-thiazol-2-yl)acetamide | - |
Escherichia coli | |
2-(4-bromophenyl)-N-(4-phenyl-1,3-thiazol-2-yl)acetamide | - |
Escherichia coli | |
2-(4-bromophenyl)-N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]acetamide | - |
Escherichia coli | |
2-(4-chlorophenyl)-N-(4-phenyl-1,3-thiazol-2-yl)acetamide | - |
Escherichia coli | |
2-(4-fluorophenyl)-N-(4-phenyl-1,3-thiazol-2-yl)acetamide | - |
Escherichia coli | |
2-phenyl-N-(4-phenyl-1,3-thiazol-2-yl)acetamide | - |
Escherichia coli | |
kanamycin B | - |
Escherichia coli | |
additional information | design, synthesis and antibacterial activity studies of thiazole derivatives as potent ecKAS III inhibitors, inhibitor antibacterial activity against the respective Gram-negative and Gram-positive bacterial strains, overview | Escherichia coli | |
N-(4-(4-bromophenyl)thiazol-2-yl)-2-(3-chlorophenyl)acetamid | the malonyl carboxylate forms hydrogen bonds to the backbone nitrogen of Phe304, inhibitor binding mode, overview | Escherichia coli | |
N-(4-phenyl-1,3-thiazol-2-yl)benzamide | - |
Escherichia coli | |
N-(4-phenyl-1,3-thiazol-2-yl)morpholine-4-carboxamide | - |
Escherichia coli | |
N-(4-phenyl-1,3-thiazol-2-yl)naphthalene-1-carboxamide | - |
Escherichia coli | |
N-(4-phenyl-1,3-thiazol-2-yl)naphthalene-2-carboxamide | - |
Escherichia coli | |
N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]-2-(3,4-diethoxyphenyl)acetamide | - |
Escherichia coli | |
N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]-2-(3-methoxyphenyl)acetamide | - |
Escherichia coli | |
N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]-2-(4-chlorophenyl)acetamide | - |
Escherichia coli | |
N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]-2-(4-fluorophenyl)acetamide | - |
Escherichia coli | |
N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]-2-phenylacetamide | - |
Escherichia coli | |
N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]benzamide | - |
Escherichia coli | |
N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]morpholine-4-carboxamide | - |
Escherichia coli | |
N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]naphthalene-1-carboxamide | - |
Escherichia coli | |
N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]naphthalene-2-carboxamide | - |
Escherichia coli | |
penicillin G | - |
Escherichia coli |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Escherichia coli | P0A6R0 | gene fabH | - |
Synonyms | Comment | Organism |
---|---|---|
beta-ketoacyl-(acyl-carrier-protein) synthase III | - |
Escherichia coli |
ecKAS III | - |
Escherichia coli |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.0053 | - |
pH and temperature not specified in the publication | Escherichia coli | N-(4-(4-bromophenyl)thiazol-2-yl)-2-(3-chlorophenyl)acetamid | |
0.0098 | - |
pH and temperature not specified in the publication | Escherichia coli | 2-(3-bromophenyl)-N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]acetamide | |
0.0123 | - |
pH and temperature not specified in the publication | Escherichia coli | 2-(3-chlorophenyl)-N-(4-phenyl-1,3-thiazol-2-yl)acetamide | |
0.0269 | - |
pH and temperature not specified in the publication | Escherichia coli | 2-(3-bromophenyl)-N-(4-phenyl-1,3-thiazol-2-yl)acetamide | |
0.0293 | - |
pH and temperature not specified in the publication | Escherichia coli | N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]-2-(4-fluorophenyl)acetamide | |
0.0347 | - |
pH and temperature not specified in the publication | Escherichia coli | N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]-2-(4-chlorophenyl)acetamide | |
0.0384 | - |
pH and temperature not specified in the publication | Escherichia coli | 2-(4-fluorophenyl)-N-(4-phenyl-1,3-thiazol-2-yl)acetamide | |
0.0418 | - |
pH and temperature not specified in the publication | Escherichia coli | 2-(4-chlorophenyl)-N-(4-phenyl-1,3-thiazol-2-yl)acetamide | |
0.0481 | - |
pH and temperature not specified in the publication | Escherichia coli | 2-(4-bromophenyl)-N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]acetamide | |
0.0656 | - |
pH and temperature not specified in the publication | Escherichia coli | N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]-2-(3-methoxyphenyl)acetamide |